Binovi Technologies Corp. (BNVIF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.14: the stock has moved about 86% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBinovi Technologies Corp. (BNVIF) trades at $0.0005. Binovi Technologies Corp. develops and commercializes visual and neuro-cognitive processing products, including hardware and software, for diagnosing and remediating visual perception disorders. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for BNVIF: BNVIF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Binovi Technologies Corp. (BNVIF) Healthcare & Pipeline Overview
Binovi Technologies Corp. specializes in developing and commercializing visual and neuro-cognitive processing solutions, including hardware and software, to diagnose and remediate visual perception disorders. Operating across Canada, the U.S., and internationally, the company offers a suite of products like Binovi Touch, Pro, and Coach, targeting vision therapy and training markets.
What Is the Investment Thesis for BNVIF?
Binovi Technologies Corp. operates within the specialized and growing segment of visual and neuro-cognitive processing, offering a suite of hardware and software solutions for diagnosing and remediating visual perception disorders. The company's gross margin of 70.7% indicates strong product-level profitability, despite a negative profit margin of -8790.2% reflecting significant operational expenses relative to revenue. A key value driver is the ongoing development of Binovi Agile and Binovi Connect, the latter being a web-based video conferencing solution that could expand market access by connecting consumers directly with vision care professionals, particularly relevant in the current healthcare landscape. The company's established product ecosystem, including Binovi Touch, Pro, Coach, and Academy, provides a foundation for recurring revenue streams through subscriptions or service agreements. Geographic expansion across Canada, the U.S., and internationally further broadens its potential customer base. However, the company's small size, with only 7 employees, and its OTC market listing as "OTC Other" with unknown disclosure status, present inherent risks regarding operational scale, funding, and transparency. Future growth hinges on successful commercialization of its development pipeline, effective market penetration, and managing its high negative profit margin towards profitability.
Based on FMP financials and quantitative analysis
BNVIF Key Highlights
Gross Margin of 70.7% indicates strong profitability at the product level.
- Negative Profit Margin of -8790.2% reflects substantial operational costs relative to current revenue generation.
- Beta of 0.14 suggests low volatility relative to the broader market.
- Development of Binovi Connect, a web-based video conferencing solution, aims to expand reach to vision care professionals and consumers.
- Operates internationally, serving markets in Canada, the United States, and other global regions.
Who Are BNVIF's Competitors?
BNVIF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| SCNX Scienture Holdings, Inc. | $0.16 | -10.33% | $6.45M | — |
| ACON Aclarion, Inc. | $2.38 | -2.46% | $6.86M | — |
| MGRX Mangoceuticals, Inc. | $0.44 | -9.03% | $7.42M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.62 | -1.72% | $11.5M | — |
| BEAT HeartBeam, Inc. | $0.43 | +3.72% | $24.1M | — |
| ONMD OneMedNet Corporation | $5.39 | -2.00% | $30.7M | — |
| EUDA EUDA Health Holdings Limited | $17.24 | +8.33% | $32.2M | — |
| CCLD CareCloud, Inc. | $2.02 | -0.98% | $85.8M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BNVIF's Key Strengths?
Specialized product suite for visual and neuro-cognitive processing disorders.
- Strong gross margin of 70.7% on products.
- Integrated hardware and software ecosystem (Touch, Pro, Coach, Academy).
- International market presence (Canada, U.S., and other regions).
What Are BNVIF's Weaknesses?
Significant negative profit margin (-8790.2%) indicating high operating costs relative to revenue.
- Small employee base (7 employees) potentially limiting scalability and operational capacity.
- OTC market listing as "OTC Other" with unknown disclosure status, impacting investor confidence and liquidity.
- Limited public financial transparency due to OTC status.
What Are the Key Risks for BNVIF?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Significant negative profit margin of -8790.2% indicates substantial operational losses, posing a going concern risk if not addressed.
- Limited public disclosure and "Unknown" disclosure status on the OTC market may deter institutional investors and impact capital raising efforts.
- Intense competition from larger, better-funded companies in the broader healthcare technology and medical device sectors.
- Small employee base (7 employees) may limit the company's capacity for rapid scaling, extensive R&D, and comprehensive market penetration.
- Reliance on successful development and commercialization of new products, where delays or market rejection could impact growth.
What Threats Does BNVIF Face?
- Intense competition from larger medical device and digital health companies.
- Regulatory hurdles and compliance costs in healthcare technology.
- Dependence on successful commercialization of new products.
- Funding challenges due to small market capitalization and negative profitability.
What Are BNVIF's Competitive Advantages?
- Specialized focus on visual and neuro-cognitive processing disorders, creating a niche market expertise.
- Integrated suite of hardware and software products, offering a comprehensive solution from diagnosis to therapy.
- Proprietary technology embedded in products like Binovi Touch and Binovi Pro.
- Established international presence in Canada, the U.S., and other markets.
- Ongoing product development pipeline, including Binovi Agile and Binovi Connect, indicating continuous innovation.
What Does BNVIF Do?
Binovi Technologies Corp., headquartered in Vancouver, Canada, is a specialized company focused on the development, manufacturing, and commercialization of advanced visual and neuro-cognitive processing products. The company's core mission revolves around providing innovative hardware and software solutions designed to diagnose and remediate various visual perception disorders. Initially known as Eyecarrot Innovations Corp., the company rebranded to Binovi Technologies Corp. in June 2020, reflecting its evolving strategic focus and product portfolio. Binovi's product ecosystem is comprehensive, catering to both professionals and end-users. Key offerings include Binovi Touch, a dedicated tool engineered for vision therapy and training applications, enabling precise and interactive exercises. Binovi Pro serves as a robust management platform, empowering doctors and trainers to efficiently oversee patient and athlete vision training regimens, track progress meticulously, and design and assign customized protocols. Complementing this, Binovi Coach provides users with clear, multimedia-guided activities, facilitating adherence and effectiveness in their assigned training programs. Furthermore, Binovi Academy functions as an educational hub, offering resources and knowledge pertinent to visual and neuro-cognitive health. The company extends its market reach across Canada, the United States, and internationally, aiming to address a broad spectrum of visual health needs. Binovi also maintains a pipeline of products under development, including Binovi Agile, which suggests future enhancements in its core offerings, and Binovi Connect, a web-based video conferencing solution designed to bridge the gap between consumers and vision care professionals, indicating a strategic move towards telehealth and remote care integration within its specialized niche. This integrated approach positions Binovi Technologies Corp. as a provider of comprehensive solutions in the visual and neuro-cognitive health sector.
What Products and Services Does BNVIF Offer?
- Develops and manufactures hardware for visual and neuro-cognitive processing.
- Creates software solutions for diagnosing visual perception disorders.
- Commercializes products for remediating visual perception disorders.
- Offers Binovi Touch for vision therapy and training exercises.
- Provides Binovi Pro for doctors and trainers to manage patient regimens and track progress.
- Supplies Binovi Coach for users to complete assigned activities with multimedia guidance.
- Maintains Binovi Academy as an educational resource for visual health.
- Developing Binovi Connect, a web-based video conferencing tool for connecting consumers with vision care professionals.
How Does BNVIF Make Money?
- Sells specialized hardware products like Binovi Touch for vision therapy.
- Generates revenue through software subscriptions or licenses for platforms like Binovi Pro and Binovi Coach.
- Potentially earns revenue from professional services, training, and educational content via Binovi Academy.
- Aims to create new revenue streams from its developing telehealth solution, Binovi Connect, possibly through usage fees or premium access.
- Operates in Canada, the United States, and other international markets.
What Industry Does BNVIF Operate In?
Binovi Technologies Corp. operates within the Medical - Healthcare Information Services industry, a segment of the broader Healthcare sector focused on leveraging technology for improved patient care and operational efficiency. This industry is experiencing significant growth driven by increasing demand for specialized diagnostic and therapeutic tools, particularly in neuro-cognitive and visual health. Market trends indicate a shift towards integrated digital health solutions, remote patient monitoring, and personalized medicine, areas where Binovi's hardware and software products align. The competitive landscape includes both established medical device manufacturers and emerging tech companies offering digital health platforms. Binovi differentiates itself by focusing specifically on visual perception disorders with a comprehensive suite of tools from diagnosis to training. The demand for such specialized solutions is fueled by a growing awareness of visual and cognitive health issues, coupled with an aging global population and increased screen time, which can contribute to various visual challenges. Binovi's position is as a niche provider, aiming to capture market share through its specialized product offerings and developing telehealth capabilities.
Who Are BNVIF's Key Customers?
- Optometrists and ophthalmologists seeking diagnostic and therapeutic tools.
- Vision therapists and trainers managing patient and athlete regimens.
- Athletes and individuals undergoing vision training.
- Consumers seeking remote visual care consultations via future Binovi Connect.
- Educational institutions utilizing visual and neuro-cognitive training programs.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Binovi Technologies Corp. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Oakville, CA. The company is led by CEO Jatinder Dhaliwal. BNVIF has traded publicly since 2017.
Financial Health
Binovi Technologies Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
BNVIF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
BNVIF Latest News
No recent news available for BNVIF.
BNVIF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BNVIF.
Price Targets
Wall Street price target analysis for BNVIF.
BNVIF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BNVIF; grades run from A+ (80-100) to F (below 30).
Leadership: Jatinder Dhaliwal
Chief Executive Officer
Jatinder Dhaliwal serves as the Chief Executive Officer of Binovi Technologies Corp. He is responsible for managing the company's small team of 7 employees, overseeing the strategic direction and daily execution of its initiatives in visual and neuro-cognitive processing solutions. His role encompasses guiding the development, manufacturing, and commercialization efforts across Canada, the United States, and internationally.
Track Record: The specific track record of key achievements and strategic decisions under Jatinder Dhaliwal's leadership is not detailed in the provided information. However, his tenure includes the company's rebranding from Eyecarrot Innovations Corp. to Binovi Technologies Corp. in June 2020, a strategic move to align the corporate identity with its evolving product focus. He oversees the ongoing development of new products like Binovi Agile and Binovi Connect, which are critical for the company's future growth trajectory.
BNVIF OTC Market Information
Binovi Technologies Corp. trades on the OTC market under the 'OTC Other' tier. This classification signifies that the company does not meet the disclosure or financial standards required for listing on higher OTC tiers like OTCQX or OTCQB, nor on major exchanges such as the NYSE or NASDAQ. Companies in the 'OTC Other' tier typically provide limited public information, often not filing with the SEC, which can result in less transparency compared to fully reporting companies. This tier is generally associated with companies that are either very small, distressed, or choose not to comply with higher disclosure requirements, making it a more speculative segment of the market for investors.
- OTC Tier: OTC Other
- Limited public information and unknown disclosure status, hindering informed investment decisions.
- Potential for significant price volatility due to low trading volume and limited liquidity.
- Higher susceptibility to fraud or manipulation compared to regulated exchanges.
- Difficulty in obtaining accurate and timely financial data for valuation and analysis.
- Challenges in raising capital due to reduced investor confidence and market access.
- Verify any available financial statements directly from the company or third-party sources.
- Research management's background and track record beyond what is publicly stated.
- Assess the company's business model and competitive landscape thoroughly, given limited data.
- Understand the regulatory environment for OTC markets and the specific 'OTC Other' tier.
- Evaluate the company's ability to generate revenue and manage its negative profit margin.
- Look for any news or press releases from reliable sources that might shed light on operations.
- Consider the potential for delisting or further restrictions on trading.
- Development and commercialization of tangible products (Binovi Touch, Pro, Coach, Academy).
- Identified CEO (Jatinder Dhaliwal) and a physical headquarters in Vancouver, Canada.
- Clear business description focused on a specific healthcare niche (visual and neuro-cognitive processing).
- Ongoing product development pipeline (Binovi Agile, Binovi Connect).
- International market presence in Canada, the U.S., and other regions.
Binovi Technologies Corp. Healthcare Stock: Key Questions Answered
How does Binovi Technologies Corp.'s small employee base impact its operational capabilities and growth prospects?
With only 7 employees, Binovi Technologies Corp. operates with a lean structure, which can offer agility and lower fixed costs.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- All information is derived solely from the provided source data. No external information or speculative content has been included.